Overview

Eran Kotler, Ph.D. is a biotech entrepreneur and scientist integrating computational biology, AI,

and translational medicine to advance precision therapeutics. He is the Co-Founder and CEO of

Cellyrix Therapeutics, a biotechnology company pioneering a platform for cell-state modulation

therapies in oncology and beyond. Prior to founding Cellyrix, Dr. Kotler was a postdoctoral

fellow at Stanford University, where he combined single-cell genomics, machine learning, and

cancer biology to uncover mechanisms of tumor evolution and therapeutic resistance.

Dr. Kotler holds a Ph.D. in Systems Biology from the Weizmann Institute of Science and a B.Sc.

in Biology from Tel Aviv University’s Adi Lautman Program for Outstanding Students. He brings

over a decade of experience spanning academia and startups at the intersection of molecular

and computational biology.